Beata Brożek

Beata Brożek

Auto-generated profile, based on publicly available information

Beata Brożek

Department of Palliative Care, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University of Torun, Bydgoszcz, Poland

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2021 in Molecules
Verified
Journal Article
Open access
PDF file
FMFernanda Monedeiro
Fernanda Monedeiro
Maciej Monedeiro-MilanowskiMaciej Monedeiro-Milanowski
Maciej Monedeiro-Milanowski
Ileana Andreea RatiuIleana Andreea Ratiu
Ileana Andreea Ratiu
BBBeata Brożek
Beata Brożek
TLTomasz Ligor
Tomasz Ligor
Bogusław BuszewskiBogusław Buszewski
Bogusław Buszewski
Volatile organic compounds (VOCs) have been assessed in breath samples as possible indicators of diseases. The present study aimed to quantify 29 VOCs (previously reported as potential biomarkers of lung diseases) in breath samples collected from controls and individuals with lung cancer, chronic obstructive pulmonary disease and asthma. Besides that, global VOC profiles were investigated. A needle trap device (NTD) was used as pre-concentration technique, associated to gas chromatography-mass spectrometry (GC-MS) analysis. Univariate and multivariate approaches were applied to assess VOC distributions according to the studied diseases. Limits of quantitation ranged from 0.003 to 6.21 ppbv and calculated relative standard deviations did not exceed 10%. At least 15 of the quantified targets presented themselves as discriminating features. A random forest (RF) method was performed in order to classify enrolled conditions according to VOCs’ latent patterns, considering VOCs responses in global profiles. The developed model was based on 12 discriminating features and provided overall balanced accuracy of 85.7%. Ultimately, multinomial logistic regression (MLR) analysis was conducted using the concentration of the nine most discriminative targets (2-propanol, 3-methylpentane, (E)-ocimene, limonene, m-cymene, benzonitrile, undecane, terpineol, phenol) as input and provided an average overall accuracy of 95.5% for multiclass prediction.

Verified
Journal Article
Open access
BBBeata Brożek
Beata Brożek
MFMałgorzata Fopka-Kowalczyk
Małgorzata Fopka-Kowalczyk
MŁMarta Łabuś-Centek
Marta Łabuś-Centek
IDIwona Damps-Konstańska
Iwona Damps-Konstańska
ARAnna Ratajska
Anna Ratajska
MKMałgorzata Krajnik
Małgorzata Krajnik
Introduction: Observations indicate that struggling with a burden of an incurable disease such as advanced chronic obstructive pulmonary disease (COPD) may result in the weakening of an individual sense of dignity, and be a source of spiritual suffering. Clinicians providing respiratory care to patients should be open to their spiritual needs, in the belief it may improve coping with the end-of-life COPD. The study aimed to assess overall feasibility and potential benefits of Dignity Therapy (DT) in patients with advanced COPD. Material and methods: Patients with severe COPD, in whom a DT intervention was implemented according to the protocol established by Chochinov et al. were included into the study. An self-designed questionnaire was applied to assess the patients’ satisfaction after intervention. Subsequently, the patients’ statements were allocated to specific problem categories, corresponding to the spiritual suffering concerns, as structured by Groves and Klauser. Results: DT was completed in 10 patients, with no unexpected side effects. Satisfaction Questionnaire showed a positive effect of DT on the patient’ well-being (3.9 on a 5-point Likert scale). The analyses of the patients’ original statements enabled an effective identification of the spiritual suffering and spiritual resources and faced by COPD patients. Conclusions: DT is an intervention well received by COPD patients, which may help them in recognising and fulfilling their spiritual needs in the last phase of their life. Information acquired on the patients’ resources and spiritual challenges may help clinicians improve their care, especially with regard to supporting their patients at the end-of-life stage.

26 March 2025 in Palliative Medicine in Practice
Verified
Journal Article
Open access
PDF file
BBBeata Brożek
Beata Brożek
IDIwona Damps-Konstańska
Iwona Damps-Konstańska
SSSzymon Skoczyński
Szymon Skoczyński
EJEwa Jassem
Ewa Jassem
MKMałgorzata Krajnik
Małgorzata Krajnik
Background: Patients with advanced chronic obstructive pulmonary disease (COPD) suffer from symptoms that significantly limit their functioning in society. Some of them fail to receive adequate support from their loved ones or relevant institutions. Moreover, since COPD is a disease of the elderly, numerous patients affected by the disease provide support to their disabled spouses. Help to such patients could be provided through home hospice care which offers psycho-physical-spiritual support, reduces the frequency of hospitalizations at the end-of-life, and takes into account the patient’s preference regarding the place of their dying. The study aimed to collect the opinions of COPD patients regarding their ability to cope with everyday challenges, the support provided to them and their loved ones, their preferences regarding the future use of palliative care, and their possible choice of the place of dying. Patients and methods: A group of 474 advanced COPD patients from three pneumonology centers in Poland (Toruń, Gdańsk, Katowice) were surveyed using a questionnaire consisting of 25 questions which the patients were asked to answer independently and anonymously. This paper presents the conclusions of the part of the survey relating to the daily functioning of the patients and their relatives. Results: One-half of the respondents declared the need for support in their daily functioning. Those having such support most frequently received it from a close family member, usually also supported by other relatives. More than 52% of respondents would be willing to benefit from palliative care if offered in the future. Given a choice of the place to die, most respondents (67.2%) would choose their own homes. Conclusions: The obtained data and patients’ statements indicate the need for institutional care for COPD patients, a better understanding of the needs of these patients and their caregivers in daily functioning, and attention to the preferences regarding the place of dying. Keywords: COPD end-of-life functioning end-of-life care